A randomized clinical trial on the comparative efficacy of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati orally in Ardhavabhedaka with special reference to Migraine
试验速览
- 阶段
- 2/3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Decrease in intensity/ duration/ frequency of headache (MIDAS/ VAS)
研究概览
简要总结
| AIMS AND OBJECTIVESAim- To conduct a randomized clinical trial on comparative efficacy of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati in the management of Ardhavbhedaka with special reference to Migraine. |
Objectives-
1. To study and establish a conceptual correlation between Ardhavabhedaka and Migraine.
2. To evaluate and compare the efficacy of trial drugs in ardhavabhedaka andMigraine*.*
RESEARCH QUESTIONWhether Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati are effective in the management of Ardhavabhedaka(Migraine)?
HYPOTHESISNULL HYPOTHESIS :
H0 -There is no effect of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi Ghan Vati in Ardhavabhedaka(Migraine).
ALTERNATE HYPOTHESIS:
H1 - There is significant difference in the effect of Gandharyadi Ghrita Nasya and Dashmooladi Ghrita Nasya along with Dhatryadi GhanVati in Ardhavabhedaka(Migraine).
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients willing to participate in this trial through written informed consent.
- •2.Both fresh and treated patients.
- •3.Patients between18 to 60 years of age from either sex.
- •4.Patients presenting with symptoms of Ardhavabhedaka vis-Ã -vis Migraine.
排除标准
- •1.Patients of age less than 18 and greater than 60 2.Patients with referred pain in one half of head due to other secondary reasons such as anxiety, refractive errors etc.
- •rather than migraine.
- •3.Patients with complicated Migraine like hemiplegic migraine and having any chronic debilitating disease with other neurological pathology.
- •4.Pregnant and lactating women.
- •5.Patients suffering from any other major systemic disorders which interfare with course of treatment.
结局指标
主要结局
Decrease in intensity/ duration/ frequency of headache (MIDAS/ VAS)
时间窗: 30 days
次要结局
- Changes in other associated symptoms of migraine:(1.Nausea)